A comparative study of cefixime and chloramphenicol in children with typhoid fever

M S Malik1, I Iqbal, W Rabbani

  • 1Department of Paediatrics, Nishtar Medical College, Multan.

Insights

Cefixime demonstrated superior efficacy compared to chloramphenicol in treating childhood typhoid fever, achieving a 93.3% cure rate. This study highlights cefixime as a more effective antibiotic option for pediatric typhoid treatment.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial therapy
  • Typhoid fever treatment

Background:

  • Typhoid fever remains a significant public health concern in children.
  • Chloramphenicol has been a traditional treatment but resistance is increasing.
  • Novel therapeutic options are needed for effective typhoid fever management.

Purpose of the Study:

  • To compare the clinical efficacy of cefixime versus chloramphenicol in children with culture-confirmed typhoid fever.
  • To evaluate cefixime as a potential alternative treatment for pediatric typhoid.

Main Methods:

  • A randomized controlled trial involving 40 children with culture-positive typhoid fever.
  • Participants were assigned to receive either oral cefixime (10 mg/kg/day) or oral chloramphenicol (50 mg/kg/day) for 14 days.
  • Clinical cure rates were assessed at the end of the treatment period.

Main Results:

  • Cefixime achieved a clinical cure in 18 out of 20 children (90%), significantly higher than chloramphenicol's 9 out of 20 (45%).
  • Ten of eleven children who failed chloramphenicol treatment were successfully cured after switching to cefixime.
  • Overall, cefixime resulted in a cure rate of 93.3% (28/30) versus 45% for chloramphenicol (P = 0.0049).

Conclusions:

  • Cefixime is significantly more effective than chloramphenicol for treating typhoid fever in children.
  • Cefixime represents a valuable and effective therapeutic option for pediatric typhoid fever, especially in areas with potential chloramphenicol resistance.